Via News Contrast:
S&P FAIR VALUE +$0.17.
(NYSE:ACV) Alberto Culver said it will not pay a special $3 dividend it was going to pay upon completing the Regis deal, and it will have a $50M charge for the termination fee for halting the deal.
(AIS) Antares Pharma filed to sell 16.6M shares for holders.
(NASDAQ:ALNY) Alnylam Pharm collaborates with US Army on RNAi therapeutics.
(APPX) American Pharma gets its NDA approved by the FDA for its Mitoxantrone Injection.
(ASVI) ASV CEO will retire in June.
(NASDAQ:AVID) Avid Tech lowered guidance.
(AVII) AVI BioPharma registered 692,000 shares for sale for holders.
(NYSE:BA) Boeing signed an agreement with China for 80 737’s.
(NYSE:CEN) Ceridian CEO will retire in October.
(NASDAQ:CGNX) Cognex gets FDA marketing approval for its EpiCeram Skin Barrier Emulsion to improve dry skin conditions.
(NASDAQ:CPKI) California Pizza Kitchen sees $0.22-0.23 EPS vs $0.22e.
(CRDN) Ceradyne slightly raised guidance.
(CZN) Citizen Communications CFO is leaving to join Global Signal.
(Private:DNA) Genentech $0.46 vs $0.41; R$1.99B vs $1.96B(e); sees 45-55% EPS growth for 2006; stock looks down $1.00 pre-market.
(DPII) Discovery Partners is making an acquisition of Infinity Pharma; will own 69% of new company but will trade under the new ticker “INFI